BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20649991)

  • 1. Health status in COPD cannot be measured by the St George's Respiratory Questionnaire alone: an evaluation of the underlying concepts of this questionnaire.
    Daudey L; Peters JB; Molema J; Dekhuijzen PN; Prins JB; Heijdra YF; Vercoulen JH
    Respir Res; 2010 Jul; 11(1):98. PubMed ID: 20649991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A psychometric assessment of the St. George's respiratory questionnaire in patients with COPD using Rasch model analysis.
    Lo C; Liang WM; Hang LW; Wu TC; Chang YJ; Chang CH
    Health Qual Life Outcomes; 2015 Aug; 13():131. PubMed ID: 26290330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The COPD assessment test and St George's Respiratory Questionnaire: are they equivalent in subjects with COPD?
    Morishita-Katsu M; Nishimura K; Taniguchi H; Kimura T; Kondoh Y; Kataoka K; Ogawa T; Watanabe F; Arizono S; Nishiyama O; Nakayasu K; Imaizumi K; Hasegawa Y
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1543-51. PubMed ID: 27462150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. French-Canadian version of the Chronic Respiratory and St George's Respiratory questionnaires: an assessment of their psychometric properties in patients with chronic obstructive pulmonary disease.
    Bourbeau J; Maltais F; Rouleau M; Guímont C
    Can Respir J; 2004 Oct; 11(7):480-6. PubMed ID: 15505701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations between disease-specific and generic health status questionnaires in patients with advanced COPD: a one-year observational study.
    Wilke S; Janssen DJ; Wouters EF; Schols JM; Franssen FM; Spruit MA
    Health Qual Life Outcomes; 2012 Aug; 10():98. PubMed ID: 22909154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the multidimensional grading system (BODE) correspond to differences in health status of patients with COPD?
    Ong KC; Lu SJ; Soh CS
    Int J Chron Obstruct Pulmon Dis; 2006; 1(1):91-6. PubMed ID: 18046907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of a linear analog scale questionnaire to measure health-related quality of life in elderly patients with chronic obstructive pulmonary disease.
    Katsura H; Yamada K; Kida K
    J Am Geriatr Soc; 2003 Aug; 51(8):1131-5. PubMed ID: 12890078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different impacts of respiratory symptoms and comorbidities on COPD-specific health-related quality of life by COPD severity.
    Lee H; Jhun BW; Cho J; Yoo KH; Lee JH; Kim DK; Lee JD; Jung KS; Lee JY; Park HY
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3301-3310. PubMed ID: 29180860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the St. George's Respiratory Questionnaire an Appropriate Measure of Symptom Severity and Activity Limitations for Clinical Trials in COPD? Analysis of Pooled Data from Five Randomized Clinical Trials.
    Loubert A; Regnault A; Meunier J; Gutzwiller FS; Regnier SA
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2103-2113. PubMed ID: 32982203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of two quality of life questionnaires in patients with COPD.
    Buss AS; Silva LM
    J Bras Pneumol; 2009 Apr; 35(4):318-24. PubMed ID: 19466269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the St George's respiratory questionnaire and risks factors affecting the quality of life of Lebanese COPD and asthma patients.
    Akiki Z; Hallit S; Layoun N; Cherfane M; Sacre H; Waked M; Salameh P
    J Asthma; 2019 Nov; 56(11):1212-1221. PubMed ID: 30359153
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial.
    Donohue JF; Bollu VK; Stull DE; Nelson LM; Williams VS; Stensland MD; Hanania NA
    Int J Chron Obstruct Pulmon Dis; 2018; 13():499-508. PubMed ID: 29440887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpretation of quality of life scores from the St George's Respiratory Questionnaire.
    Ferrer M; Villasante C; Alonso J; Sobradillo V; Gabriel R; Vilagut G; Masa JF; Viejo JL; Jiménez-Ruiz CA; Miravitlles M
    Eur Respir J; 2002 Mar; 19(3):405-13. PubMed ID: 11936515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between degree of dyspnoea and health-related quality of life in patients with chronic obstructive pulmonary disease].
    Gvozdenović BS; Mitić S; Zugić VG; Gvozdenović AT; Lazović NM; Plavsić S
    Srp Arh Celok Lek; 2007; 135(9-10):547-53. PubMed ID: 18088040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the minimal important difference for the feeling thermometer and the St. George's Respiratory Questionnaire in patients with chronic airflow obstruction.
    Schünemann HJ; Griffith L; Jaeschke R; Goldstein R; Stubbing D; Guyatt GH
    J Clin Epidemiol; 2003 Dec; 56(12):1170-6. PubMed ID: 14680667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational study.
    Oga T; Tsukino M; Hajiro T; Ikeda A; Nishimura K
    Respir Res; 2012 Sep; 13(1):85. PubMed ID: 23006638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity and reliability of the St. George's Respiratory Questionnaire in assessing health status in patients with chronic pulmonary aspergillosis.
    Al-Shair K; Atherton GTW; Kennedy D; Powell G; Denning DW; Caress A
    Chest; 2013 Aug; 144(2):623-631. PubMed ID: 23188518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health status in the TORCH study of COPD: treatment efficacy and other determinants of change.
    Jones PW; Anderson JA; Calverley PM; Celli BR; Ferguson GT; Jenkins C; Yates JC; Vestbo J; Spencer MD;
    Respir Res; 2011 May; 12(1):71. PubMed ID: 21627828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities.
    Wacker ME; Jörres RA; Karch A; Wilke S; Heinrich J; Karrasch S; Koch A; Schulz H; Watz H; Leidl R; Vogelmeier C; Holle R;
    BMC Pulm Med; 2016 May; 16(1):70. PubMed ID: 27160582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised controlled equivalence trial to determine the effectiveness and cost-utility of manual chest physiotherapy techniques in the management of exacerbations of chronic obstructive pulmonary disease (MATREX).
    Cross J; Elender F; Barton G; Clark A; Shepstone L; Blyth A; Bachmann M; Harvey I;
    Health Technol Assess; 2010 May; 14(23):1-147, iii-iv. PubMed ID: 20487638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.